Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms

S Kang, T Kishimoto - Experimental & molecular medicine, 2021 - nature.com
Abstract Interleukin-6 (IL-6) plays a crucial role in host defense against infection and tissue
injuries and is a bioindicator of multiple distinct types of cytokine storms. In this review, we …

Targeting interleukin-6 signaling in clinic

S Kang, T Tanaka, M Narazaki, T Kishimoto - Immunity, 2019 - cell.com
Interleukin-6 (IL-6) is a pleiotropic cytokine with roles in immunity, tissue regeneration, and
metabolism. Rapid production of IL-6 contributes to host defense during infection and tissue …

IL-6 revisited: from rheumatoid arthritis to CAR T cell therapy and COVID-19

T Kishimoto, S Kang - Annual review of Immunology, 2022 - annualreviews.org
The diverse biological activity of interleukin-6 (IL-6) contributes to the maintenance of
homeostasis. Emergent infection or tissue injury induces rapid production of IL-6 and …

Pleiotropy and specificity: insights from the interleukin 6 family of cytokines

M Murakami, D Kamimura, T Hirano - Immunity, 2019 - cell.com
Since the molecular cloning of interleukin-6 (IL-6) in 1986, many other cytokines have been
found to share the same signal transducer, gp130, in their receptor complexes. Thus, the IL …

Castleman disease

A Carbone, M Borok, B Damania, A Gloghini… - Nature Reviews …, 2021 - nature.com
Castleman disease (CD), a heterogeneous group of disorders that share morphological
features, is divided into unicentric CD and multicentric CD (MCD) according to the clinical …

Interleukin-6 in biology and medicine

S Akira, T Taga, T Kishimoto - Advances in immunology, 1993 - Elsevier
Publisher Summary This chapter focuses on structure and expression of interleukin-6 (IL-6),
which is a cytokine with pleiotropic activities that plays a central role in host defense. IL-6 …

Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty

WB Ershler, ET Keller - Annual review of medicine, 2000 - annualreviews.org
Interleukin-6 (IL-6) is a proinflammatory cytokine that is normally tightly regulated and
expressed at low levels, except during infection, trauma, or other stress. Among several …

Identification of miR-145 and miR-146a as mediators of the 5q–syndrome phenotype

DT Starczynowski, F Kuchenbauer, B Argiropoulos… - Nature medicine, 2010 - nature.com
Abstract 5q–syndrome is a subtype of myelodysplastic syndrome characterized by severe
anemia and variable neutropenia but normal or high platelet counts with dysplastic …

HHV-8-negative, idiopathic multicentric Castleman disease: novel insights into biology, pathogenesis, and therapy

DC Fajgenbaum, F van Rhee… - Blood, The Journal of the …, 2014 - ashpublications.org
Multicentric Castleman's disease (MCD) describes a heterogeneous group of disorders
involving proliferation of morphologically benign lymphocytes due to excessive …

The pathophysiologic roles of interleukin-6 in human disease

DA Papanicolaou, RL Wilder… - Annals of internal …, 1998 - acpjournals.org
Interleukin-6, an inflammatory cytokine, is characterized by pleiotropy and redundancy of
action. Apart from its hematologic, immune, and hepatic effects, it has many endocrine and …